Viela Bio

Investors/Media

Press Releases

Press Releases

4.30.2020
Viela Bio Announces Election of Rachelle Jacques to its Board of Directors
GAITHERSBURG, Md. , April 30, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the election of Rachelle Jacques to its Board of Directors.
3.25.2020
Viela Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
Company to host investor conference call and webcast today at 5:00 pm ET GAITHERSBURG, Md. , March 25, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today reported financial results and
3.18.2020
Viela Bio to Webcast Fourth Quarter and Full Year 2019 Operating and Financial Results on March 25, 2020
GAITHERSBURG, Md. , March 18, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, March 25, 2020 at 5:00 p.m.
Displaying 11 - 13 of 13

Shareholder Tools